SynopsisThe global Still's Disease Treatment market was valued at US$ 1785.2 million in 2023 and is anticipated to reach US$ 2513.5 million by 2030, witnessing a CAGR of 4.9% during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion .....
SynopsisThe global Renal Anemia Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, grow.....
SynopsisThe global Venipuncture Procedure market was valued at US$ 771.5 million in 2023 and is anticipated to reach US$ 993.5 million by 2030, witnessing a CAGR of 3.2% during the forecast period 2024-2030. The global market for medical devices is estimated at .....
SynopsisThe global HIV-1 Screening Tests market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. North American market for HIV-1 Screening Tests is estimated to increa.....
SynopsisThe global Insomnia Pharmacological Treatment market was valued at US$ 2921.6 million in 2023 and is anticipated to reach US$ 3710.3 million by 2030, witnessing a CAGR of 3.4% during the forecast period 2024-2030. The global pharmaceutical market is 1475.....
SynopsisThe global Polycystic Kidney Disease Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in .....
SynopsisThe global Paroxysmal Nocturnal Hemoglobinuria Treatment market was valued at US$ 3324.1 million in 2023 and is anticipated to reach US$ 5939.2 million by 2030, witnessing a CAGR of 8.5% during the forecast period 2024-2030. The global pharmaceutical mar.....
SynopsisThe global African Trypanosomiasis Treatment market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 20.....
SynopsisThe global Severe Acute Respiratory Syndrome (SARS) Therapeutics market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030. The global pharmaceutical market is 14.....
SynopsisAlpha-1 antitrypsin deficiency (A1AD) is a hereditary disorder characterized by low levels of a protein called alpha-1 antitrypsin (A1AT) which is found in the blood. This deficiency may predispose an individual to several illnesses and most commonly manifests.....
